AMD’s AI Advantage May Just Be Getting Started
While the spotlight often shines brightest on Nvidia, another chipmaker has been clawing its way into the conversation and could soon be in a position to steal the show.
That company is Advanced Micro Devices (NASDAQ: AMD), and it’s gearing up to report second-quarter earnings early next month.
With the stock already up 34% this year,
» Read more about: AMD’s AI Advantage May Just Be Getting Started »
Read More
Nvidia Just Matched Microsoft in Value, So Is It Still a Smart Buy?
Nvidia (NASDAQ: NVDA) just pulled off something extraordinary, again. Fiscal Q1 2026 numbers weren’t just good, they were extraordinary.
Management reported a top line of $44.1 billion, up 69% from the same time last year, and 12% higher than the previous quarter. Net income was an eye-popping $18.8 billion, and that’s in spite of a $4.5 billion charge tied to new U.S.
» Read more about: Nvidia Just Matched Microsoft in Value, So Is It Still a Smart Buy? »
Read More
Will Archer Aviation Make Flying Taxis a Reality?
For decades, flying cars have been the stuff of science fiction. But now, they’re inching closer to becoming part of our everyday lives and Archer Aviation (NYSE: ACHR) is one of the startups trying to make that future take off.
Archer is building what’s known as eVTOLs, electric vertical takeoff and landing aircraft.
» Read more about: Will Archer Aviation Make Flying Taxis a Reality? »
Read MoreThis Tiny AI Stock May Triple by 2030, Almost No One’s Watching
SoundHound AI isn’t the biggest name in artificial intelligence right now, not when companies like Nvidia and Microsoft are grabbing all the headlines.
But SoundHound may very well turn out to be one of the most surprisingly valuable small-cap AI stocks by the time 2030 rolls around. There’s a real story unfolding here and it’s starting to show up in the numbers.
» Read more about: This Tiny AI Stock May Triple by 2030, Almost No One’s Watching »
Read More
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Ivy
Is Ambiq the Answer to AI’s Biggest Blind Spot?
AI might be the future, but that future has a power problem. For all the fanfare surrounding generative AI, one inconvenient truth continues to lurk in the background, which is it consumes an extraordinary amount of energy.
And unless someone cracks the code on power efficiency, scaling AI beyond the data center and into billions of edge devices will remain an expensive dream.
» Read more about: Is Ambiq the Answer to AI’s Biggest Blind Spot? »
Read MoreThe Spotlight
Can You Really Earn a 100% Yield From This Tesla-Based ETF?
A wave of funds has popped up promising double-digit income yields, many of them built on familiar covered call tactics. But one issuer, YieldMax, has taken the concept to an entirely different level. Think 30%, 50%, even 100%-plus yields.
The poster child is the YieldMax Tesla Option Income Strategy ETF, ticker TSLY. This fund aims to milk income from Tesla (NASDAQ: TSLA) by trading options,
» Read more about: Can You Really Earn a 100% Yield From This Tesla-Based ETF? »
Read MoreThe Daily
Analytics Insight Cryptocurrency Analysis for July 2025: Bitcoin Hits $119K, Ethereum Soars 48%, XRP Jumps 45%
Bitcoin opened July near $107,000 before surging to a record-breaking $119,000. The rally established a bullish flag formation supported by higher highs, consistent volume, and resilient absorption of selling pressure.
Immediate Resistance: $121,000-$130,000
Key Support: $116,000-$112,000
Momentum: RSI 67-73, MACD positive
A daily close above $121,000 could propel BTC toward $130,000,